ClinicalTrials.gg
RecruitingNCT06503198VICTORYUpdated Oct 26, 2026

The VICTORY Trial: Virtual, Innovative, Postsurgical Care To Optimize Return Home for Older People With frailtY

An interventional study of Virtual care in Surgery and Frailty, sponsored by Ottawa Hospital Research Institute. Recruiting at 1 site in Canada. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-10-26.

Sponsored by Ottawa Hospital Research Institute · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jan 2025; still recruiting 1 year 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
1,000
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 83 studies in Frailty with a site in Canada — 23 open to participants now, 34 under way, none of them phase 3. Frailty · Canada.

Planned enrollment
4th of 60
1,000 · median 80
Started
2025
with 7 others
No phase
58 of 83
16 open now
Primary completion
2028-01
later than 28 of 33 live
Registered
74th of 83
by date
Lead sponsor
5 of 83
Ottawa Hospital Research Institute

Among the 83 studies in Frailty with a site in Canada, this one is the 4th largest by planned enrollment of the 60 interventional ones that give a count, is one of 8 that started in 2025, is one of 58 with no phase, reaches primary completion later than 28 of the 33 other live ones, and was the 74th registered.

Frailty

1,291 studies on the registry are indexed under Frailty; 454 are open to participants now.

Browse Frailty studies →

Open to participants now

23 of the 83 studies in Frailty with a site in Canada are open now. Recruiting first, the newest first:

17 more — sign in →

All 23 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 299 Frailty studies recruiting now, 235 (79%) set no upper age limit and 10 (3%) stop at 75 or younger; 7 take children under 18; 66 take healthy volunteers.

This study: 60 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 83 studies in Frailty with a site in Canada, or all of them as a file.
02

Study summary

Canadian hospitals continue to struggle with severe emergency department and hospital bed capacity shortages. Maximizing bed availability and minimizing emergency department and urgent-centre visits by providing patients with alternative options to care is an important part of the solution. Surgical patients with frailty are at high risk of requiring subsequent acute-hospital care. The VICTORY trial will answer an important question that will inform how to improve care for surgical patients with frailty by determining the effect of virtual care with CloudDX technology compared to standard care to see if it can result in an increase in the number of days alive and at home that older people with frailty experience after planned surgery.

Read the detailed description

Background: Each year, >130,000 older Canadians living with frailty have major, inpatient surgery. The presence of frailty, a multidimensional state of vulnerability, is strongly associated with adverse outcomes. Compared to similar patients without frailty, surgical patients with frailty experience a 2- to 5-fold adjusted increase in the odds of mortality, complications, patient-reported disability, length of stay, readmissions and non-home discharge. However, despite the growing number of patients with frailty presenting for surgery each year, a recent systematic review from our team demonstrates that there are no evidence-based, frailty-specific interventions available to drive improvements in outcomes for this vulnerable population. A promising intervention to support independence and maintain older people at home after surgery is Virtual Recovery After Surgery (VRAS), an innovative multidisciplinary program that has been providing post-discharge remote monitoring and virtual care for surgical patients since 2021. Patients receive virtual care from the VRAS nursing and anesthesiologist team following surgical discharge, facilitated by Cloud DX software and monitoring equipment. Based on our team's joint expertise in frailty and Postoperative Virtual Care (PVC), the investigators have identified: 1) a crucial gap in care expressed by older patients with frailty (the need for support and continuity of care via telehealth resources to support transition of care to their homes), and 2) an intervention that could directly fill this gap (frailty tailored PVC).

Overarching Aim: The objective of the VICTORY Trial is to determine the effect of virtual care with CloudDX technology compared to standard care to see if it can result in an increase in the number of days alive and at home that older people with frailty experience in the 30 days after planned surgery. A secondary aim is to estimate the probability that enrollment in a frailty-tailored PVC program will reduce healthcare resource use and improve patient-reported outcomes and safety.

Methods:

Design, setting and participants: The VICTORY Trial is a multicenter, innovative clinical trial using an individual patient, parallel-arm randomized controlled trial design of 1,000 older patients living with frailty being discharged from hospital after elective surgery.

People ≥60 years old with frailty having elective surgery will be included.

Intervention: Patients randomized to the PVC program will be monitored at home by virtual nurses for at least 7 days after hospital discharge. Participants will be provided with a hospital-to-home kit that contains the following technologies: tablet computer (with stand), wrist-based blood pressure cuff (for blood pressure, pulse and breathing rate), finger worn pulse oximeter (for measuring oxygen levels), thermometer (for temperature) and weigh scale (to monitor weight). Monitoring will include video visits with a nurse on post-discharge days 1, 3, 5 and 7 and every other day until post-discharge day 14 if needed. Patients will be asked to complete a daily survey that will include questions about any symptoms they may be experiencing, their independence/dependence with activities of daily living, and their experience with the PVC program. Depending on the patient's recovery (including the assessments and surveys described), patients may receive information electronically on how to manage certain challenges (i.e., confusion, not eating enough), their care may be escalated to a physician, or they may be instructed to come to the hospital.

An internal pilot study (N=96) is embedded within the multicentre VICTORY effectiveness trial to evaluate the feasibility of trial procedures, with a focus on recruitment, intervention adherence, and participant retention.

Outcomes and sample size: The primary outcome is the number of days that each patient spends alive and at home following surgery. Secondary outcomes are: resource use (index length of stay, readmission, total hospital days, emergency department visits, time to first acute hospital care, cost of care), patient-centered outcomes (delirium (4AT), quality of life (EQ- 5D-5L), pain interference (PROMIS), satisfaction (likelihood to recommend), goal attainment, and overall quality of transitional care received), safety (medication issues, incidence of post-discharge falls).

Based on trial simulations, the investigators estimate that the most likely number of participants required will be 1000 (500 per arm), which is adequate to achieve at least 90% power to declare superiority (defined as probability of any benefit = 99% (P(Odds Ratio (OR)>1) = 99%) when the effect size, expressed as an OR from a cumulative logistic model, is 1.5 and the control group number of days alive at home within 30 days is 16.

Expertise: Our team features multidisciplinary clinical and methodological experts, nationally representative knowledge users and patient representatives.

Expected outcomes: The VICTORY Trial will: 1) advance the practice of PVC using evidence-based, frailty-tailored approaches; 2) evaluate this frailty-tailored PVC intervention in direct partnership with patients; and 3) produce robust, potentially practice-changing research using innovative clinical trial methodologies that will inform implementation.

03

Conditions studied

  • Surgery
  • Frailty

Browse trials for

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age > 60years
  2. Diagnosis of frailty (Clinical Frailty Score >4)
  3. Elective surgery
  4. Fluent in English

Exclusion criteria

Exclusion Criteria:

  1. Preoperative institutional residence
  2. Planned postoperative non-home discharge (i.e. rehabilitation or convalescence)
  3. Patient unable to interact with virtual care and/or technology
  4. Cognitive impairment preventing ability to provide independent to surgery and the trial
  5. Patient lives in an area without cellular or internet service
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
1,000 participants (estimated)

Study arms

  • Experimental
    Virtual Care

    Intervention group participants will be enrolled in a PVC program prior to admission, including receipt of a cellular-enabled tablet and Cloud DX remote monitoring equipment. Through Cloud DX remote monitoring technology, intervention group participants will receive the following intervention: remote automated monitoring, frailty-tailored daily symptom survey, Katz Index of Independence in Activities of Daily Living survey, FAM-CAM survey, Virtual RN assessment, medications.

    Behavioral: Virtual care

  • No intervention
    Standard Care

    The standard care group will receive their post-hospital discharge management in alignment with standard of care at the hospital where they had surgery.

Interventions

  • BehavioralVirtual care

    Through Cloud DX, intervention group participants will receive: Remote Automated Monitoring: measurement of: blood pressure, heart rate, respiratory rate, oxygen saturation, temperature and weight. Frailty-tailored daily symptom survey: The recovery survey consists of questions related to infection, bleeding, pain, appetite, dehydration, appetite, syncope and falls. The tablet will prompt the participant to complete a Katz Index of Independence in Activities of Daily Living (IADL) survey. The FAM-CAM survey will also be pushed by Cloud DX to be completed. Virtual RN assessment: a virtual RN assessment will be scheduled at a minimum of every 2 days for the first 7 days. The virtual RN will also perform the 4AT Delirium Assessment. Medications: the virtual RN will undertake medication review and reconciliation. In addition, they will provide counselling regarding analgesic support and monitor for drug interactions.

06

What researchers measure

Primary outcomes

  1. Number of days each patient spends alive and at home following surgery

    This validated, patient-centered outcome is calculated as the sum of all days alive within 30-days of surgery minus any days spent in hospital (index or readmission), rehabilitation, or nursing home/long term care centers. Death will be assigned a '-1' value; those surviving 30-days will be assigned an outcome value of their count of days alive and at home

    Time frame: 30 days

Other outcomes

  1. Resource use- Index length of stay

    Count of days from date of surgery to hospital discharge will be documented

    Time frame: 30 days

  2. Resource use- Readmission

    Any acute care hospitalization after index hospital discharge and within 30-days and 365-days of surgery will be documented

    Time frame: 30 days, 1 year

  3. Resource use- Readmission length of stay

    Sum of total counts of days from start of new acute care admission to discharge where the New admissions occurring within 30 days of index surgery will be documented

    Time frame: 30 days

  4. Resource use- 30-day total hospital days

    Count of all days spent in an acute care hospital from surgery to 30-days after surgery will be documented

    Time frame: 30 days

  5. Resource use- Number of Emergency Department visits

    Count of Emergency Department visits occurring between index surgery and 30-days and 365-days after surgery will be documented

    Time frame: 30 days, 1 year

  6. Resource use- Time to first acute hospital care

    Count of days from index surgical admission discharge to first Emergency Department visit or readmission will be documented

    Time frame: 30 days

  7. Resource use- Costs of care

    For Ontario patients, standardized case costing methods will be used to estimate total health system costs from date of surgery to 30-days and 365-days after surgery

    Time frame: 30 days, 1 year

  8. Patient-centered- Delirium (4AT)

    Captured using the UltraBrief, a separate delirium screening tool from the 4AT Confusion Assessment Methods utilized as part of the intervention delirium screening. A score of 4 or more suggests delirium but is not diagnostic. A score of 1-3 suggests cognitive impairment and more detailed cognitive testing and informant history-taking may be indicated. A score of 0 does not definitively exclude delirium or cognitive impairment: more detailed testing may be needed depending on the clinical context.

    Time frame: Days 1 and 3 post-discharge

  9. Overall quality of transitional care received

    Using the Ideal Transitions in Care (ITC) Framework, which has 10 domains to consider to ensure safe transitions of care. Number of domains will be reported.

    Time frame: 30 days

  10. Quality of life (EQ- 5D-5L)

    This is a well-validated instrument with Canadian valuation statistics and national implementation used to measure health-related quality of life after surgery and to inform incremental cost per quality-adjusted life year gained. Participants are asked to select one answer under each domain (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression). Responses range from having no problems with a particular domain to being unable to engage in that particular domain. Participants are asked to identify on a scale of 0-100 how good or bad their health is on that given day (0 being worst health they can imagine, 100 being best health they can imagine).

    Time frame: 30 days, 90 days

  11. Pain interference (PROMIS)

    The 6-item Short Form 6b V1.0 will be used to capture interference of pain. Item-levels are scored numerically for an individual's response to each question. Higher scores means more of the concept being measured. The lowest raw score is 6 and the highest raw score is 30.

    Time frame: 30 days, 90 days

  12. Satisfaction (Likelihood to Recommend)

    Patients will complete the 'Likelihood to recommend' question, reflecting on a 10-point scale their likelihood to recommend their postoperative transitional care experience

    Time frame: 30 days

  13. Personalized goal attainment

    A method of evaluating the extent to which patient's individual goals are achieved in the course of an intervention, previously used in rehabilitation studies for older adults with frailty, using an 11-point Likert scale; this outcome directly aligns with the 5th geriatric 'M' (matters most) where participants report the most important benefit from surgery and rate the achievement of the goal on a scale from worse than before surgery to much better than I expected after surgery

    Time frame: 30 days, 90 days

  14. Safety- Incidence of post-discharge falls

    Falls post-discharge

    Time frame: 30 days

  15. Safety- Medication issues using the Treatment Satisfaction Questionnaire for Medications (TSQM) scale

    The virtual registered nurse will undertake medication review and reconciliation on day 1 and day of discharge from program. In addition, they will provide counselling regarding analgesic support and monitor for drug interactions. Questions from the TSQM scale will be administered. The degree to which medication side effects affected overall satisfaction will be reported on a scale from extremely satisfied to not at all. How satisfied or dissatisfied the participant is with the medications will be reported on a scale from very satisfied to very dissatisfied.

    Time frame: Day of discharge from program post-surgery (assessed up to day 6)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Individual participant data, including data dictionaries, will be available. This includes individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices). The Study Protocol, Statistical Analysis Plan and Informed Consent Form will also be made available. Data will be available beginning 3 months and ending 5 years following article publication of one year follow up data. Data will be shared with researchers who provide a methodologically sound proposal. Data can be used to achieve aims in a proposed proposal or for individual participant data meta-analysis. Proposals should be directed to the Principal Investigator. To gain access, data requestors will need to sign a data access agreement. Data will be shared via an appropriate 3rd party website that is consistent with ethical and health privacy compliant legislation at the time of study conclusion.

Supporting information: Statistical analysis plan

Time frame: Data will be available beginning 3 months and ending 5 years following article publication of one year follow up data.

Access criteria: Data will be shared with researchers who provide a methodologically sound proposal. Data can be used to achieve aims in a proposed proposal or for individual participant data meta-analysis. Proposals should be directed to the Principal Investigator. To gain access, data requestors will need to sign a data access agreement. Data will be shared via an appropriate 3rd party website that is consistent with ethical and health privacy compliant legislation at the time of study conclusion.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2025 (actual). Primary completion is estimated for Jan 2028, 36 months after the start.

Of 514 non-industry interventional studies with no phase under Frailty, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 39. This study's planned 36 months is above that.

Counting every sponsor, half of 519 studies reached it within 22 months; a quarter within 10 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 24, 2024
First posted
Jul 16, 2024
StartActual
Jan 29, 2025
Primary completionEst.
Jan 31, 2028
CompletionEst.
Jan 31, 2030
Last update
Oct 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Minor edits
Nothing that changes what the study is or who can join. Edited: index terms, verification date and description
1 update, last Oct 26, 2026
Show all 1 update
  1. Oct 26, 2026
    Minor edits only
    + 3 other changes: index terms, verification date and description

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06503198
Responsible party
Sponsor
First posted
Jul 16, 2024
Start date
Jan 29, 2025
Primary completion
Jan 31, 2028 (estimated)
Completion
Jan 31, 2030 (estimated)
Last update
Oct 26, 2026

Study contacts

Emily Hladkowicz, PhD
Contact
emhladkowicz@toh.ca
613-798-5555 ext. 18629
Sylvie Aucoin, MD
principal investigator · The Ottawa Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion